Compounding Magazine Vaccines 
Pharmaceutical Technology
JULY 2, 2025
How will RFK Jr’s American dream for vaccines play out? The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed.
Pharmaceutical Technology
JUNE 30, 2025
How will RFK Jr’s American dream for vaccines play out? The planned 160,000ft² facility will focus on aseptic production and includes areas for material preparation and compounding. Find out more Ground preparation work for the new site commenced in April after obtaining the building permit.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 13, 2025
CSPC will use its AI-powered drug discovery platform, which uses the technology to analyse the binding patterns of target proteins with existing compound molecules. Can pharma tariffs “Make America Manufacture Again”? The AI models work out targeted optimisation, advancing small molecules with the best developability.
Pharmaceutical Technology
JUNE 27, 2025
Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now? Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 receptor agonists (GLP-1RA), due to the emergence of compounded alternatives in the past few years.
Pharmaceutical Technology
JUNE 27, 2025
In March 2025, Novo Nordisk discounted the cost of all doses to $499 per month to competitively price its prized asset against cheaper compounded alternatives. Compounded semaglutide is a personalised weight loss medicine, which is chemically identical to branded alternatives.
Pharmaceutical Technology
JUNE 13, 2025
The myasthenia gravis (MG) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the US) is poised to grow at a compound annual growth rate of 5.3% Can pharma tariffs “Make America Manufacture Again”? Credit: Vitalii Vodolazskyi via Shutterstock. billion in 2024 to $10.3
Pharmaceutical Technology
JULY 8, 2025
How will RFK Jr’s American dream for vaccines play out? The pulmonary arterial hypertension (PAH) market is forecast to grow at a compound annual growth rate (CAGR) of 2.0% Credit: Green Apple via Shutterstock. The disease primarily affects middle-aged women and has a poor long-term prognosis despite therapeutic advances.
Expert insights. Personalized for you.
52 
Let's personalize your content